Allogene Therapeutics published new long-term follow-up data on cemacabtagene ansegedleucel, showing the investigative ...

Your immune system harbors a lifetime's worth of information about threats it's encountered - a biological Rolodex of baddies ...

Immunotherapy is the form of treatment that redirects the immune system toward a pathogen or disease. In many cases, ...

University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of ...

Scientists engineered T cells to protect instead of kill, potentially enabling targeted treatments for autoimmune disease and ...

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

One-shot’ approach that uses machine learning to screen immune cells could help to detect conditions with overlapping ...

Hematopoietic and lymphocytic neoplasms (HLNs) are a diverse group of malignancies affecting blood and lymphatic systems, with outcomes varying from manageable conditions to fatal diseases.

CAR T-cell therapy showed efficacy in relapsed large B-cell lymphoma across age groups, including patients 70 and 80 years or older.

During a Case-Based Roundtable® event, Natalie Galanina, MD, discussed data from the ZUMA-7 and TRANSFORM trials in the first ...